Hjem › Galleveiskreft (kolangiokarcinom) › Kentucky
Kliniske studier for Galleveiskreft (kolangiokarcinom) i Kentucky
4 studier for Galleveiskreft (kolangiokarcinom) søker deltakere på steder i Kentucky.
Byer i Kentucky
Offisiell studietekst (engelsk)
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Norton Cancer Institute (Site 115), Louisville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07265674Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Norton Cancer Institute - Audubon, Louisville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06282575A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Norton Cancer Institute - Norton Healthcare Pavilion, Louisville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07169734Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
- University of Kentucky, Lexington
RekruttererFase 2
Alder 18 til 99 · Alle kjønn · Oppdatert 4. feb. 2026 · NCT07201519Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.